Weekly Policy Update: CMS Proposed Rule is a Step Forward for the Coverage of Breakthrough Technologies
By: Colorado BioScience Association Date: 05/13/2019
In late April, the Centers for Medicare and Medicaid Services (CMS) publicly released its FY 2020 Inpatient Prospective Payment System (IPPS) Proposed Rule. The rule is a critical step forward for coverage and payment of medical devices, and makes it more likely that breakthrough products will be covered and adequately paid for by CMS.
The proposed changes will help stimulate innovation and help to ensure that patients have access to these novel, groundbreaking technologies.
CBSA continues to work closely with our partners at AdvaMed to advocate for policies that will reduce coverage and payment disincentives for new, innovative technologies.